CT-P13
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for CT-P13, covering 2013-03-12 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid Arthritis [Phase 3]